Sub: Disclosure pursuant to Regulation 11, 30 and 37 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 REF: COMPOSITE SCHEME OF AMALGAMATION BETWEEN ARTEMIS GLOBAL LIFE SCIENCES LIMITED ('COMPANY'), ARTEMIS HEALTH SCIENCES LIMITED ('AHSL'), ATHENA EDUSPARK LIMITED ('AEL') AND ARTEMIS MEDICARE SERVICES LIMITED ('AMSL') AND THEIR RESPECTIVE SHAREHOLDERS AND CREDITORS. Dear Sir/ Madam, With reference to our letter dated December 20, 2018 regarding National Company Law Tribunal (NCLT), New Delhi Bench Order dated 19th December, 2018 directing Artemis Global Life Sciences Limited to convene Shareholder meeting on 27th January, 2019 and Artemis Medicare Services Limited to convene creditors (secured and unsecured) meeting on 27th January, 2019 respectively. Further, we wish to submit the followings: 1. Copy of the notice to Equity Shareholder of the Company for their meeting scheduled to be held on Sunday, January 27, 2019 at 10.00 A.M. at 414/1, 4th Floor, DDA Commercial Complex, District Centre, Janakpuri, New Delhi-110058 (Annexure A). 2. Copy of the notice to Secured Creditor of Artemis Medicare Services Limited for their meeting scheduled to be held on Sunday, January 27, 2019 at 12.00 P.M. at 414/1, 4th Floor, DDA Commercial Complex, District Centre, Janakpuri, New Delhi-110058 (Annexure B). 3. Copy of notice to Unsecured Creditor of Artemis Medicare Services Limited for their meeting scheduled to be held on Sunday, January 27, 2019 at 1.00 P.M. at 414/1, 4th Floor, DDA Commercial Complex, District Centre, Janakpuri, New Delhi-110058 (Annexure C). The above notice is also uploaded on the website of the Company viz. https://aglsl.in/composite-scheme-of-amalgamation/ Today we had sent...